ENAGenomicsUNIVERSITY OF NORTH CAROLINA AT CHAPEL HILLhttps://www.ebi.ac.uk/ena/browser/view/PRJEB52596NAENAstudy, Microbial Community Composition, positional, Community Composition, Microbiomes, positional polypeptide feature, Microbial Community Compositions, region or site annotation, Microbial Community, Microbial Community Structure, Community Structure, Microbial, sample population, Human, Composition, geographical area, sample, Microbial Community Structures, sequence, Microbiotas, primary structure of sequence macromolecule., variable, Human Microbiomes, Microbial Communities, Community, Human Microbiome, MicrobiomeCystic fibrosis NOS, mixed phenotype acute leukaemia, Bile salt-stimulated lipase, sulfactin, Sterol esterase, susceptibility to chronic infection by, Meconium obstruction of intestine in mucoviscidosis, Sputums, Pancreas Fibrocystic Diseases, FCAALL.51, expectoration, Pancreatic lysophospholipase, 3-dithiopropanol, British antilewisite, CONSTITUTIVE 1, 3-dimercaptopropanol, Cholate--CoA ligase, 3-mercaptopropan-1-ol, SUPPRESSOR OF NPR1-1, 1, 2, cystic fibrosis with other manifestations (disorder), AW214463, 2-propanedithiol, cystic fibrosis lung disease, modifier of, Meconium ileus in cystic fibrosis (disorder), adult, Pulmonary, 3-dimercaptol-1-propanol, dimercaprol, ARTD9, 3-hydroxy-1, cystic fibrosis with meconium ileus, Cystic Fibrosis of Pancreas, cystic fibrosis with other manifestations, Solute carrier family 27 member 5, 2-dimercapto-3-propanol, mixed phenotype acute leukemia, rBAL-1, cystic fibrosis with combined manifestations, cystic fibrosis with gastrointestinal manifestations, Fibrocystic disease, CF, Cystic Fibrosis, 2-dithioglycerol, acute leukaemia of undetermined lineage, FATP-5, dithioglycerol, BA-CoA ligase, Pulmonary Cystic Fibrosis, BSSL, Sputum, Very long-chain acyl-CoA synthetase-related protein, pseudomonas aeruginosa, dimercaprolum, dimercaptopropanol, cystic fibrosis with pulmonary manifestations (disorder)., Mucoviscidosis, beta-dithioglycerol, Cystic fibrosis NOS (disorder), biphenotypic acute leukemia, Bssl, VLACS-related, Bagl, 1810036E18Rik, CF - Cystic fibrosis, cystic fibrosis with pulmonary manifestations, 6.2.1.7, British anti-Lewisite, ALL with myeloid markers, Carboxyl ester lipase, CYSTIC FIBROS W/O ILEUS, British anti-lewisite, 3-Mercaptopropanol, Induced Sputum, 3-dimercapto-1-propanol, Pancreatic, Fibrosis, VLACSR, Adults, Induced Sputums, 3.1.1.13, in cystic fibrosis, Cystic fibrosis (disorder), Bile acid-CoA ligase, Pancreatic Cystic Fibrosis, Cholesterol esterase, biphenotypic acute leukaemia, DL4475C, Cystic fibrosis without mention of meconium ileus, cystic fibrosis, alpha, 3.1.1.3, cystic fibrosis with meconium ileus (disorder), Fibrocystic Disease of Pancreas, BALL, Cystic, PARP-9, acute leukemia of undetermined lineage, mucoviscidosis, Bal, BAL, BC003281, Pancreas Fibrocystic Disease, dithioglycerine, Fatty acid transport protein 5, BACS, AML with lymphoid markers, 3-Dimercapto-1-propanol, InducedfalseDublin, Belfast, Chapel Hill Sputum and BAL samples from adults with Cystic FibrosisMulti-visit multi-sample microbiome study collecting variable region data2022-05-042022-05-04PRJEB52596